awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36653598-66F8D31C-2DC0-4854-96D5-5C0D50B578D2
Q36653598-66F8D31C-2DC0-4854-96D5-5C0D50B578D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36653598-66F8D31C-2DC0-4854-96D5-5C0D50B578D2
A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer.
P2860
Q36653598-66F8D31C-2DC0-4854-96D5-5C0D50B578D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36653598-66F8D31C-2DC0-4854-96D5-5C0D50B578D2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
37162bdad633ed02ac0c6befff0cfde7d27593ce
P2860
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer.